Patented and Innovative Clean Tech Products and Solutions
​
Full-Service Engineering
​
Clean Air, Clean Water. Unparalleled Technologies
BioLargo Companies
Click to learn more:
About BioLargo
​
BioLargo invents, patents, and develops innovative platform technologies for three markets: 1) advanced water and wastewater treatment, 2) industrial odor and VOC control, and 3) advanced wound care products. With a wide array of issued patents, an extensive R&D talent pool, and a full-service engineering team, the company maintains a robust pipeline of products from inception through maturity. BioLargo monetizes its technology assets with the goal of maximizing both impact and shareholder value, using licensing, strategic partnership, and direct-to-market strategies.
BioLargo Technologies
CupriDyne Clean Industrial Odor and VOC Eliminator:
-
Eliminates odors; doesn't mask them
-
Non-toxic, non-sensitizing, non-fragranced
-
Effective against VOCs, ammonia, sulfur compounds, mercaptans, fatty acids
-
Misting systems: design, build, install, maintain, service options available
​
Click HERE to learn more
The Advanced Oxidation System (AOS):
-
Exceptional disinfection performance with concurrent decontamination
-
Ultra low energy consumption
-
Lower costs than competitors (OPEX and CAPEX)
-
Modular - Flexible - Scalable
​
Click HERE to learn more
Clyra Advanced Wound Care Products:
-
Infection control, chronic wound therapy, regenerative tissue therapy
-
Non-cytotoxic, safe, broad-spectrum antimicrobial action. Efficacy proven.
-
No bacterial resistance.
-
Hydrogels, dressings, liquids
-
First product FDA 510(k) approved
​
Click HERE to learn more
Aqueous Electrostatic Concentrator
-
Cost- and energy-efficient elimination of per- and polyfluoroalkyl substances (PFAS) from contaminated water
-
More affordable than carbon-based sequestration
-
Solution huge, pressing need for effective PFAS treatment globally
​
BioLargo Blog
The Edison Group Analyst Reports for BioLargo
Investor Relations Page
Click the link above to access the Investor Relations Page, which includes information about BioLargo, Inc. businesses for stockholders, potential investors, and financial analysts.
